Parkman Healthcare Partners’s iRhythm Holdings IRTC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.74M Buy
+40,125
New +$5.79M 0.49% 58
2022
Q4
Sell
-25,458
Closed -$3.19M 89
2022
Q3
$3.19M Sell
25,458
-48,543
-66% -$7.01M 0.91% 41
2022
Q2
$7.99M Sell
74,001
-29,980
-29% -$3.97M 2.94% 10
2022
Q1
$16.4M Buy
103,981
+42,001
+68% +$5.39M 4.79% 1
2021
Q4
$7.29M Buy
61,980
+29,480
+91% +$2.7M 1.61% 24
2021
Q3
$1.9M Buy
+32,500
New +$1.72M 0.48% 55

Other funds holding IRTC

Parkman Healthcare Partners's IRTC Position: Q1 2026 in Review

Parkman Healthcare Partners opened a new position in iRhythm Holdings (IRTC) in Q1 2026: 40,125 shares worth $4.74M. The stake represents 0.49% of the portfolio and ranks #58 among its holdings. This is a return to the name: Parkman Healthcare Partners previously reported a position in IRTC as recently as Q3 2022.

Parkman Healthcare Partners first reported a position in IRTC in Q3 2021 and has held it in 6 quarters since. The position peaked at $16.4M in Q1 2022. 304 funds tracked by Wall St. Rank hold IRTC as of Q1 2026.

  • Parkman Healthcare Partners held 40,125 shares of iRhythm Holdings worth $4.74M as of Q1 2026.
  • iRhythm Holdings was a new Parkman Healthcare Partners position in Q1 2026.
  • iRhythm Holdings made up 0.49% of Parkman Healthcare Partners's portfolio in Q1 2026, its #58 holding.
  • Parkman Healthcare Partners first reported a position in iRhythm Holdings in Q3 2021 and has held it in 6 quarters since.
  • Parkman Healthcare Partners's iRhythm Holdings position peaked at $16.4M in Q1 2022.
  • 304 funds tracked by Wall St. Rank held iRhythm Holdings as of Q1 2026.

Based on Parkman Healthcare Partners's 13F filing for Q1 2026, filed 15 May 2026.